These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 14086288)

  • 1. [ANTIMYCOBACTERIAL ACTIVITY OF ISOXYL. STUDIES IN VITRO AND MICE].
    TRNKA L; URBANCIK R; POLENSKA H
    Pathol Microbiol (Basel); 1963; 26():817-33. PubMed ID: 14086288
    [No Abstract]   [Full Text] [Related]  

  • 2. [ANTIMYCOBACTERIAL ACTIVITY OF ISOXYL. II. EXPERIMENTS WITH GUINEA PIGS AND RABBITS].
    URBANCIK R; TRNKA L; KRUML J; POLENSKA H
    Pathol Microbiol (Basel); 1964; 27():79-87. PubMed ID: 14107358
    [No Abstract]   [Full Text] [Related]  

  • 3. DETERMINATION OF THE SENSITIVITY OF MYCOBACTERIA TO ISOXYL IN VITRO.
    VIRTANEN S
    Ann Med Exp Biol Fenn; 1963; 41():430-5. PubMed ID: 14085830
    [No Abstract]   [Full Text] [Related]  

  • 4. [STUDY IN VITRO OF 4-4'-DIISOAMYLOXYTHIOCARBANILIDE ON COLONIES OF MYCOBACTERIUM TUBERCULOSIS ISOLATED FROM TUBERCULOUS PATIENTS].
    BORDABOSSANA D
    Sem Med; 1964 Mar; 124():687-91. PubMed ID: 14167977
    [No Abstract]   [Full Text] [Related]  

  • 5. IN VITRO TESTS WITH 4,4'-DIISOAMYLOXYTHIOCARBANILIDE.
    EIDUS L; HAMILTON EJ
    Am Rev Respir Dis; 1964 Aug; 90():258-60. PubMed ID: 14197720
    [No Abstract]   [Full Text] [Related]  

  • 6. [ISOXYL, IN COMBINATION WITH OTHER ANTIMYCOBACTERIAL DRUGS, IN THE THERAPY OF CHRONIC PULMONARY TUBERCULOSIS].
    GIURA F
    Riforma Med; 1964 Sep; 78():1058-9. PubMed ID: 14223407
    [No Abstract]   [Full Text] [Related]  

  • 7. [TOXICOLOGICAL STUDY OF ISOXYL ON ANIMALS].
    LAMBELIN G; PARMENTIER R
    Acta Tuberc Pneumol Belg; 1963; 54():476-93. PubMed ID: 14116427
    [No Abstract]   [Full Text] [Related]  

  • 8. Unique mechanism of action of the thiourea drug isoxyl on Mycobacterium tuberculosis.
    Phetsuksiri B; Jackson M; Scherman H; McNeil M; Besra GS; Baulard AR; Slayden RA; DeBarber AE; Barry CE; Baird MS; Crick DC; Brennan PJ
    J Biol Chem; 2003 Dec; 278(52):53123-30. PubMed ID: 14559907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative study of thiocarbonylides (isoxyl and ethoxide) under experimental and clinical conditions].
    Shmelev NA; Kozulitsyna TI; Utkin VV; Poleshchuk AK; Stepanian ES
    Probl Tuberk; 1966; 44(6):13-23. PubMed ID: 4968672
    [No Abstract]   [Full Text] [Related]  

  • 10. [STUDIES ON CHEMOTHERAPEUTICS FOR MYCOBACTERIUM TUBERCULOSIS. XVI. SYNTHESIS AND ANTIBACTERIAL ACTIVITY ON MYCOBACTERIUM TUBERCULOSIS OF PHENYLTHIOUREA DERIVATIVES].
    FUJIKAWA F; HIRAI K; NAKATANI Y; IMANISHI K; NAITO M; TSUKUMA S
    Yakugaku Zasshi; 1964 Oct; 84():993-8. PubMed ID: 14250878
    [No Abstract]   [Full Text] [Related]  

  • 11. [Frequency of Conteben resistance and its significance in the occurrence of isoxyl (4,4'-diisoamyloxythiocarbanilide) resistance in tubercle bacilli].
    Meissner G
    Prax Pneumol; 1965 Jul; 19(7):387-95. PubMed ID: 4953606
    [No Abstract]   [Full Text] [Related]  

  • 12. [ON THE EXPERIMENTAL EVALUATION OF THE TUBERCULOSTATIC ISOXYL].
    FREERKSEN E; ROSENFELD M
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1963 Aug; 127():386-97. PubMed ID: 14042690
    [No Abstract]   [Full Text] [Related]  

  • 13. [EXPERIMENTS IN THE TREATMENT OF EXPERIMENTAL TUBERCULOSIS IN GUINEA PIGS WITH 4,4'-DIISOAMYLOXYTHIOCARBANILIDE (ISOXYL)].
    KANAI K; OKAMOTO S; MUROHASHI T
    Kekkaku; 1963 Oct; 38():470-3. PubMed ID: 14092914
    [No Abstract]   [Full Text] [Related]  

  • 14. CLINICAL EXPERIENCE OF ISOXYL.
    RISKA N; PEKKANEN PS
    Acta Tuberc Pneumol Scand; 1964; 45():168-78. PubMed ID: 14215790
    [No Abstract]   [Full Text] [Related]  

  • 15. [MULTIPLICATION OF MYCOBACTERIUM LEPRAE; POSSIBILITY OF SENSITIVITY TESTING].
    JADIN L; WERY M; MORIS R
    Bull Acad Natl Med; 1964 Apr; 148():333-42. PubMed ID: 14152230
    [No Abstract]   [Full Text] [Related]  

  • 16. [ACTIVITY OF 4-4' DIISOAMYLOXYTHIOCARBANILIDE ON EXPERIMENTAL TUBERCULOSIS OF THE GUINEA PIG].
    NITTI V; CATENA E; NINNI A
    Arch Tisiol Mal Appar Respir; 1964 Nov; 19():859-88. PubMed ID: 14339285
    [No Abstract]   [Full Text] [Related]  

  • 17. [TRIAL OF 4,4'-DIISOAMYLOXYTHIOCARBANILIDE IN THE TREATMENT OF PULMONARY TUBERCULOSIS].
    LESTON JM; PALERMO FM; GONZALEZMONTANER LJ; DAMBROSI A
    Sem Med; 1964 Mar; 124():543-8. PubMed ID: 14156392
    [No Abstract]   [Full Text] [Related]  

  • 18. THE EFFECTIVENESS OF A THIOCARBANILIDE (ISOXYL) AS A THERAPEUTIC DRUG IN MOUSE TUBERCULOSIS.
    CROWLE AJ; MITCHELL RS; PETTY TL
    Am Rev Respir Dis; 1963 Nov; 88():716-7. PubMed ID: 14082688
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of pulmonary tuberculosis with Isoxyl (bacteriological considerations)].
    Taranger J
    Rev Tuberc Pneumol (Paris); 1967; 31(1):68-72. PubMed ID: 4962524
    [No Abstract]   [Full Text] [Related]  

  • 20. [EXPERIMENTAL AND CLINICAL EVALUATION OF A NEW TUBERCULOSTATISTATIC AGENT, 4,4'-DIISOAMYLOXYTHIOCARBANILIDE].
    JADIN J; LAMBOTTE F
    Ann Soc Belg Med Trop (1920); 1963 Oct; 43():723-8. PubMed ID: 14122080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.